Duan Y, Ren X, Guo X, Xie J, Liu Z, Li L
Front Immunol. 2025; 15:1466839.
PMID: 39742253
PMC: 11685136.
DOI: 10.3389/fimmu.2024.1466839.
Wu Y, Liang J, Mi R, Wang L, Chen L, Wei X
Sci Rep. 2024; 14(1):29161.
PMID: 39587191
PMC: 11589753.
DOI: 10.1038/s41598-024-80496-x.
Cazzola M, Malcovati L
Haematologica. 2024; 110(2):312-329.
PMID: 39445412
PMC: 11788631.
DOI: 10.3324/haematol.2023.284947.
Yan Y, Yu Y, Xiong W, Wang J, Yao Y, Jia Y
Clin Cancer Res. 2024; 30(23):5483-5493.
PMID: 39373694
PMC: 11609624.
DOI: 10.1158/1078-0432.CCR-23-3939.
Mao J, Ge J, Ding S, Sun Z, Nan F, Yu H
Sci Rep. 2024; 14(1):22356.
PMID: 39333693
PMC: 11437004.
DOI: 10.1038/s41598-024-72897-9.
Domain affiliated distilled knowledge transfer for improved convergence of Ph-negative MPN identifier.
Reza M, Alam M, Rahman R, Dipto S
PLoS One. 2024; 19(9):e0303541.
PMID: 39331624
PMC: 11433141.
DOI: 10.1371/journal.pone.0303541.
High-grade B-cell lymphoma with 11q aberration in the HIV setting: a clinicopathological study of 10 cases and literature review.
Chang J, Liang Y, Gao Y, Wu M, Lv F, Liu H
Infect Agent Cancer. 2024; 19(1):42.
PMID: 39261841
PMC: 11391791.
DOI: 10.1186/s13027-024-00604-4.
Enhancing diagnostic precision in EBV-related HLH: a multifaceted approach using F-FDG PET/CT and nomogram integration.
Yang X, Lu X, Feng L, Wang W, Kan Y, Zhang S
Cancer Imaging. 2024; 24(1):108.
PMID: 39155389
PMC: 11330599.
DOI: 10.1186/s40644-024-00757-w.
Case report: Mutation evolution in a patient with TdT positive high grade B cell lymphoma with MYC and BCL2 rearrangements following the treatment of concurrent follicular lymphoma and diffuse large B-cell lymphoma.
Zhang F, Chen Y, Cui Q, Ge Y, Liu Y
Discov Oncol. 2024; 15(1):129.
PMID: 38662249
PMC: 11045710.
DOI: 10.1007/s12672-024-00991-5.
Obstructive Sleep Apnea Does Not Exclude Polycythemia Vera: A Case Report.
Afana M, Abu-Tineh M, Alshurafa A, Ahmed K, Abdulgayoom M, Yassin M
Case Rep Oncol. 2024; 17(1):91-95.
PMID: 38213957
PMC: 10783889.
DOI: 10.1159/000535742.
T cell posttransplant lymphoproliferative disorder after kidney transplantation progressing to acute liver failure: a case report.
Cho J, Kim Y, Min S, Kim T, Lee H
Korean J Transplant. 2023; 37(4):299-305.
PMID: 38057946
PMC: 10772273.
DOI: 10.4285/kjt.23.0045.
Editorial: Understanding leukemia biology using genome editing techniques.
Jimenez-Morales S, Banerjee K, Saha N, Basu A, McGraw K
Front Oncol. 2023; 13:1323584.
PMID: 38023172
PMC: 10660276.
DOI: 10.3389/fonc.2023.1323584.
Enhanced tumor immunotherapy by polyfunctional CD19-CAR T cells engineered to secrete anti-CD47 single-chain variable fragment.
Qiu Y, Liao P, Wang H, Chen J, Hu Y, Hu R
Int J Biol Sci. 2023; 19(15):4948-4966.
PMID: 37781520
PMC: 10539696.
DOI: 10.7150/ijbs.86632.
Case Report: Non-negligible Epstein-Barr virus-associated posttransplant lymphoproliferative disorders in a lung transplant recipient.
Hu J, Yu Y, Han D, Li X, Zhang Y, Cai H
Front Immunol. 2023; 14:1244534.
PMID: 37781359
PMC: 10540203.
DOI: 10.3389/fimmu.2023.1244534.
Machine Learning Predicts 30-Day Outcome among Acute Myeloid Leukemia Patients: A Single-Center, Retrospective, Cohort Study.
Lee H, Han J, Kim J, Yoo J, Yoon J, Cho B
J Clin Med. 2023; 12(18).
PMID: 37762881
PMC: 10531920.
DOI: 10.3390/jcm12185940.
Oligosecretory Waldenström macroglobulinemia exhibits excellent treatment response and outcomes.
Xiong W, Yu Y, Sun C, Du J, Cai Z, Wang Z
Haematologica. 2023; 109(2):666-670.
PMID: 37706332
PMC: 10828770.
DOI: 10.3324/haematol.2023.283402.
Cytogenetic profile of Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia in Northern Pakistan.
Khan M, Altaf C, Malik H, Naeem M
Pak J Med Sci. 2023; 39(5):1440-1445.
PMID: 37680814
PMC: 10480755.
DOI: 10.12669/pjms.39.5.6405.
BR vs. R‑miniCHOP in unfit patients with B‑cell non‑Hodgkin lymphoma: A randomized, two‑center, cohort study.
Zhang D, Lin Y, Dong Y, Zhang L
Oncol Lett. 2023; 26(4):440.
PMID: 37664664
PMC: 10472019.
DOI: 10.3892/ol.2023.14027.
Nanobody-derived bispecific CAR-T cell therapy enhances the anti-tumor efficacy of T cell lymphoma treatment.
Xia B, Lin K, Wang X, Chen F, Zhou M, Li Y
Mol Ther Oncolytics. 2023; 30:86-102.
PMID: 37593111
PMC: 10427987.
DOI: 10.1016/j.omto.2023.07.007.
Chimeric antigen receptor T cells march into T cell malignancies.
Tang J, Zhao X
J Cancer Res Clin Oncol. 2023; 149(14):13459-13475.
PMID: 37468610
DOI: 10.1007/s00432-023-05148-5.
